[Federal Register Volume 85, Number 230 (Monday, November 30, 2020)]
[Notices]
[Pages 76575-76576]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-26258]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of

[[Page 76576]]

which would constitute a clearly unwarranted invasion of personal 
privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CK-21-001, US Travelers 
Health Research, Surveillance, Communication, and Outreach Network; 
RFA-CK-21-002, Emerging Infections Network--Research for Preventing, 
Detecting, and Managing Travelers who Acquire Infectious Diseases 
Abroad; and RFA-CK-21-003, Monitoring Cause-specific School Absenteeism 
for Estimating Community-wide Influenza and SARS-CoV-2 Transmission.
    Date: February 10-11, 2021.
    Time: 10:00 a.m.-5:00 p.m., EST.
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1080, 8 Corporate Square Boulevard, Atlanta, GA 30329.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027, (404) 718-8833, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-26258 Filed 11-27-20; 8:45 am]
BILLING CODE 4163-18-P